SELECTIVE GUT DECOMTAMINATION REDUCES HEPATIC EXPRESSION OF TOLL-LIKE RECEPTOR (TLR) 4 AND DEVELOPMENT OF CIRRHOSIS BUT DOES NOT PREVENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC)

被引：0

作者：

Mohamed, F. E. Z. ^{[1
]}

Dhar, D.

Shah, N. ^{[1
]}

Davies, N. ^{[1
]}

Habtesion, A. ^{[1
]}

Luong, T. V. ^{[2
]}

Winstanley, A. ^{[3
]}

Dhillon, A. P. ^{[2
]}

Mookerjee, R. P. ^{[1
]}

Jalan, R. ^{[1
]}

机构：

[1] Royal Free Hosp, UCL, London NW3 2QG, England

[2] Royal Free Hosp Hampstead NHS Trust, London, England

[3] Univ Coll London Hosp, London, England

来源：

JOURNAL OF HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

293

引用

页码：S121 / S121

页数：1

共 50 条

[21] Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients
Neamatallah, Mustafa
El-Bendary, Mahmoud
Elalfy, Hatem
Besheer, Tarek
Abd El-Maksoud, Mohamed
Elhammady, Dina
Abed, Sally
Elegezy, Mohamed
Kandeel, Lamiaa
Eldeib, Dalia
Mousa, Naser
Abd El-Hafeez, Mohamed
El-Gilany, Abdel-Hady
Esmat, Gamal
IMMUNOLOGICAL INVESTIGATIONS, 2020, 49 (04) : 462 - 476
[22] Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma
Kataki, Kangkana
Borthakur, Parikhit
Kumari, Namrata
Deka, Manab
Kataki, Amal Ch
Medhi, Subhash
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (06) : 1008 - 1014
[23] Discovery and development of Toll-like receptor 4 (TLR4) antagonists: A new paradigm for treating sepsis and other diseases
Leon, Carlos G.
Tory, Rita
Jia, Jessica
Sivak, Olena
Wasan, Kishor M.
PHARMACEUTICAL RESEARCH, 2008, 25 (08) : 1751 - 1761
[24] Toll-like receptor 4 signaling is required for induction of gluconeogenic gene expression by palmitate in human hepatic carcinoma cells
Mamedova, Laman K.
Yuan, Kai
Laudick, Amber N.
Fleming, Sherry D.
Mashek, Douglas G.
Bradford, Barry J.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (08): : 1499 - 1507
[25] DORSAL ROOT GANGLIA (DRG) NEURONS PREVENT CELL SURFACE EXPRESSION OF TOLL-LIKE RECEPTOR-4 (TLR4) ON GLIAL CELLS
Wise, H.
Tse, K.
Chow, K.
Leung, W.
Wong, Y.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 186 - 186
[26] Effects of prophylactic antibiotics on toll-like receptor (TLR) 2 and 4 expression on peripheral blood mononuclear cells (PBMC) in patients with decompensated cirrhosis
Testro, A. G.
Visvanathan, K.
Skinner, N. A.
Markovska, V.
Wongseelashote, S.
Angus, P. W.
Gow, P. J.
JOURNAL OF HEPATOLOGY, 2008, 48 : S38 - S38
[27] The role of toll-like receptor 4 (TLR4) in epithelial-macrophage cross-talk in the development of intestinal neoplasia
Fukata, Masayuki
Hernandez, Yasmin
Breglio, Keith J.
Conduah, Daisy E.
Chen, Anli
Xu, Ruliang
Hsu, David
Ungaro, Ryan
Abreu, Maria T.
GASTROENTEROLOGY, 2008, 134 (04) : A26 - A26
[28] Differentiation expression of toll-like receptor4 (TLR4) caused by the dysregulation of microRNA-140-5p is responsible for the development of postoperation infection
Zheng, Ge
Li, Zhishu
Xiang, Wenna
Huang, Yumao
Pan, Minli
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3479 - 3490
[29] Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma
Pan, Caixu
Wu, Qinchuan
Wang, Shuai
Mei, Zhibin
Zhang, Lele
Gao, Xingxing
Qian, Junjie
Xu, Zhentian
Zhang, Ke
Su, Rong
Guo, Danjing
Zhou, Lin
Zheng, Shusen
ONCOIMMUNOLOGY, 2022, 11 (01):
[30] Toll-like receptor (TLR3) signaling in human hepatocellular carcinoma (HCC) depends on the tumor-associated long-noncoding RNA H19
Paulus, Patrick
Urbschat, Anja
Reissig, Christin
Zacharowski, Kai
Drse, Stefan
Scheller, Bertram
Tybl, Elisabeth
CANCER RESEARCH, 2014, 74 (19)

← 1 2 3 4 5 →